Detalhe da pesquisa
1.
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients.
Int J Gynecol Cancer
; 29(2): 325-333, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30700568
2.
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient.
J Exp Med
; 213(7): 1133-9, 2016 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27242164
3.
T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression.
J Clin Oncol
; 34(31): 3787-3795, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27269940
4.
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I.
Cancer Immunol Res
; 2(1): 27-36, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24432305